A detailed history of Vectors Research Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Vectors Research Management, LLC holds 12,178 shares of PFE stock, worth $334,407. This represents 0.11% of its overall portfolio holdings.

Number of Shares
12,178
Previous 12,178 -0.0%
Holding current value
$334,407
Previous $341,000 2.93%
% of portfolio
0.11%
Previous 0.1%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$25.26 - $29.6 $1,439 - $1,687
-57 Reduced 0.47%
12,178 $341,000
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $5,178 - $5,946
200 Added 1.66%
12,235 $340,000
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $7,839 - $10,182
-300 Reduced 2.43%
12,035 $349,000
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $66,330 - $77,533
-2,067 Reduced 14.35%
12,335 $391,000
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $76,393 - $88,385
-2,115 Reduced 12.8%
14,402 $528,000
Q1 2023

May 04, 2023

SELL
$39.39 - $51.28 $24,343 - $31,691
-618 Reduced 3.61%
16,517 $674,000
Q4 2022

Feb 08, 2023

SELL
$41.75 - $54.5 $1,377 - $1,798
-33 Reduced 0.19%
17,135 $878,000
Q3 2022

Nov 08, 2022

SELL
$43.76 - $53.42 $25,205 - $30,769
-576 Reduced 3.25%
17,168 $751,000
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $4,373 - $5,185
-94 Reduced 0.53%
17,744 $930,000
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $40,809 - $50,567
-892 Reduced 4.76%
17,838 $923,000
Q4 2021

Feb 15, 2022

BUY
$41.32 - $61.25 $101,523 - $150,491
2,457 Added 15.1%
18,730 $1.11 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $45,137 - $57,983
-1,150 Reduced 6.6%
16,273 $700,000
Q2 2021

Aug 09, 2021

BUY
$35.91 - $40.68 $5,027 - $5,695
140 Added 0.81%
17,423 $682,000
Q1 2021

May 18, 2021

BUY
$33.49 - $37.77 $87,777 - $98,995
2,621 Added 17.88%
17,283 $626,000
Q4 2020

Feb 09, 2021

SELL
$33.47 - $42.56 $57,802 - $73,501
-1,727 Reduced 10.54%
14,662 $540,000
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $89,376 - $104,858
2,815 Added 20.74%
16,389 $498,000
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $34,336 - $41,655
1,140 Added 9.17%
13,574 $444,000
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $84,198 - $120,301
-3,115 Reduced 20.03%
12,434 $406,000
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $167,069 - $189,602
-5,075 Reduced 24.61%
15,549 $609,000
Q3 2019

Nov 15, 2019

SELL
$32.49 - $42.13 $31,482 - $40,823
-969 Reduced 4.49%
20,624 $741,000
Q2 2019

Aug 12, 2019

BUY
$36.98 - $41.52 $73 - $83
2 Added 0.01%
21,593 $935,000
Q1 2019

Jul 15, 2019

BUY
$37.5 - $41.2 $223,162 - $245,181
5,951 Added 38.05%
21,591 $917,000
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $517,844 - $590,399
13,461 Added 617.76%
15,640 $683,000
Q3 2018

Nov 15, 2018

BUY
$34.47 - $41.81 $75,110 - $91,103
2,179 New
2,179 $792,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Vectors Research Management, LLC Portfolio

Follow Vectors Research Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vectors Research Management, LLC with notifications on news.